Portfolio Companies News
December 11, 2017HealthTech company Doctrin raises S...
HealthTech company Doctrin raises SEK 100 million in a Series A round led by healthcare provider Capio and Life Science fund HealthCap, with Inbox Capital and Norrsken Foundation as co-investors. The investment enables Doctrin to accelerate expansion in Sweden and internationally, as well as f... read more
December 11, 2017Nexstim Plc has entered into an agr...
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or the "Company"), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announced in a company release published on 16 October 2017 that it was... read more
December 11, 2017Targovax announces that first combi...
Oslo, Norway, 11 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that clinical trials investigating ONCOS-102 in the treatment of melanoma and mesothelioma have successfully passed their respec... read more
December 11, 2017Betalutin® shows strong clinical p...
Updated data reported at the 59th Annual American Society of Hematology (ASH) meeting Oslo, Norway, 11 December 2017 Nordic Nanovector ASA (OSE: NANO) has presented updated results from its LYMRIT 37-01 Phase 1/2 clinical study of Betalutin® (177Lu-satetraxetan-lilotomab) in patients with r... read more
December 10, 2017Oncopeptides presented survival dat...
Stockholm – December 10th, 2017 – Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the first survival data were presented at the annual meeting of the American Society of Hematology from the phase II-study O-12-M1 in late-stage patients with Relapsed Refractory Multiple Myelom... read more
November 13, 2017Q3 2017 General Market Overview
Since the start in 1996, HealthCap funds have invested in 110 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
24 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.